- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01034761
Using Clinical Alerts to Decrease Inappropriate Medication Prescribing
Using Clinical Alerts in a Computerized Provider Order Entry System to Decrease Inappropriate Medication Prescribing Among Hospitalized Elders
Introduction:
The Beers list identifies medications that should be avoided in persons 65 years or older because they are ineffective, pose an unnecessarily high risk, or a safer alternative is available. In a recent study, we found a high rate of prescribing of Beers list medications to hospitalized patients. At Baystate, 41% of medical patients received at least one Beers list drug classified as "high severity," meaning it carried a high risk for an adverse drug reaction, while 5% received 3 or more. Some Beers drugs have been associated with delirium and falls. When compared to Baystate patients who did not receive a high severity medication, those who did had an increased risk of mortality (7.8% vs. 5.2%), longer length of stay (5.5 days vs. 3.9 days) and higher costs ($11,240 vs. 6243).
Specific Aims:
- Quantify the impact of synchronous electronic alerts on physician prescribing of high-severity Beers' list drugs to hospitalized patients over the age of 65 years.
- Compare physician reactions to each drug-specific alert
Project Description:
We will develop a series of clinical alerts in CIS, Baystate's computerized provider order entry system, to reduce the use of potentially inappropriate medications among hospitalized elders. We will randomize providers to electronic alerts or usual care. Whenever a provider randomized to alerts attempts to place an order for a high-risk medication on the Beers list and the intended recipient is over 65 years of age, a synchronous alert (i.e. a "pop-up") will inform the physician about the risks associated with the medication and will propose safer alternatives.
We will collect data on physician ordering and patient outcomes comparing the number of Beers list prescriptions from providers receiving electronic alerts to those not receiving alerts. Our anticipated outcome is a decrease in inappropriate prescribing during the period when the electronic alerts are activated. Other potential outcomes include decrease in length of stay and a decrease in falls.
Studieoversikt
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Massachusetts
-
Springfield, Massachusetts, Forente stater, 01199
- Baystate Medical Center
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Hospitalized patients with Age > 65
Exclusion Criteria:
- None
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Ingen inngripen: Vanlig omsorg
|
|
|
Eksperimentell: Pop-up alerts
Providers will receive pop-up alerts in the electronic medical record when prescribing one of the specified medications from the Beers list.
|
Pop-up alert in the electronic medical record whenever the provider enters an order for a specified high risk medication from the Beers list.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The percentage of elderly patients who receive a specified high-risk medication from the Beer's list.
Tidsramme: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
The average number of specified high risk medications prescribed per patient.
Tidsramme: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Restraint use
Tidsramme: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Falls
Tidsramme: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Length of stay
Tidsramme: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Total Cost
Tidsramme: Earlier of hospital stay or end of study
|
Earlier of hospital stay or end of study
|
|
Discharge status
Tidsramme: 6 months
|
6 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Linda J Canty, MD, Baystate Medical Center
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- 132454
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Pop-up alert
-
Children's Hospitals and Clinics of MinnesotaFullførtMindre hodeskadeForente stater
-
Children's Healthcare of AtlantaEmory UniversityFullførtPediatrisk Preoperativ angst, Pediatrisk mestringForente stater
-
University Rovira i VirgiliEuropean Commission; Hospital Universitari Sant Joan de Reus; Centro Tecnológico... og andre samarbeidspartnereFullførtOvervekt | LivsstilSpania
-
University Of PerugiaFullførtUrininkontinens | BekkenorganprolapsItalia
-
University of CincinnatiChildren's Hospital Medical Center, Cincinnati; The Kroger CompanyFullførtHypertensjon | Overvekt | Kostholdsendringer | HyperlipidemierForente stater
-
Dana-Farber Cancer InstituteFullførtBrystkreft | Mage-tarmkreft | Oral kreftrettet terapi | Oral kjemoterapiForente stater
-
Society for Gynecological Surgery in FinlandAktiv, ikke rekrutterende
-
Medical University of South CarolinaSouth Carolina Clinical & Translational Research Institute (SCTR)Aktiv, ikke rekrutterendeTobakksbruksforstyrrelseForente stater
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) og andre samarbeidspartnereRekrutteringMetabolsk dysfunksjon-assosiert Steatotisk leversykdomForente stater